Table 2.
Bevacizumab-Related Adverse Events
| Toxicity | No. of Events |
|||
|---|---|---|---|---|
| Grade 1 | Grade 2 | Grade 3 | Grade 4 | |
| Thromboembolic event | 2 | 4 | ||
| Hypertension | 4 | 2 | ||
| Hypophosphatemia | 1 | 2 | ||
| Thrombocytopenia | 2 | 1 | ||
| Hepatic dysfunction | 1 | |||
| Proteinuria | 1 | |||
| Bowel perforation | 1 | |||
Bevacizumab-Related Adverse Events
| Toxicity | No. of Events |
|||
|---|---|---|---|---|
| Grade 1 | Grade 2 | Grade 3 | Grade 4 | |
| Thromboembolic event | 2 | 4 | ||
| Hypertension | 4 | 2 | ||
| Hypophosphatemia | 1 | 2 | ||
| Thrombocytopenia | 2 | 1 | ||
| Hepatic dysfunction | 1 | |||
| Proteinuria | 1 | |||
| Bowel perforation | 1 | |||